Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Automotive Industry Today.
Press releases published on July 31, 2025
ZenaTech’s ZenaDrone Initiates AUVSI Membership Upgrade, Enabling Leadership on Drone Policy and Strengthening US Defense and Government Engagement
GlobeNewswire
·
July 31, 2025
VANCOUVER, British Columbia, July 31, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a business technology solution provider specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), …
Anavex Life Sciences Announces Positive Precision Medicine Results from up to 4-Years of Oral Blarcamesine Treatment in Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease
GlobeNewswire
·
July 31, 2025
New clinical Precision Medicine population data demonstrates up to 84.6 Weeks (19.5 Months) ‘time saved’ by early-start ADAS-Cog13 difference: −5.43 (P = 0.0035), ADCS-ADL difference: +9.50 (P < 0.0001) Restoring impaired autophagy as early event, …
Effective Date of Consolidation of Shares
GlobeNewswire
·
July 31, 2025
Vancouver, British Columbia , July 31, 2025 (GLOBE NEWSWIRE) -- First American Uranium Inc. (CSE: URM) (FSE: IOR) (OTCPK: FAUMF) (the “Company”) announces, further to its news release of July 21, 2025 and effective August 6, 2025, the Company will …
MariMed’s Products to Enter Pennsylvania Market Through a Management Services and Licensing Agreement with TILT Holdings
GlobeNewswire
·
July 31, 2025
NORWOOD, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, today announced a strategic agreement with TILT Holdings (“TILT”) (CBOE: …
Psyence BioMed’s Strategic Collaboration with PsyLabs Yields Breakthrough in High-Purity Ibogaine Production
GlobeNewswire
·
July 31, 2025
NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”) is pleased to announce that its strategic partner, PsyLabs – a leader in the production of purified psychedelic compounds – has …
InflaRx to Report Second Quarter 2025 Results on August 7, 2025
GlobeNewswire
·
July 31, 2025
JENA, Germany, July 31, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that the Company will report its second quarter 2025 …
Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization
GlobeNewswire
·
July 31, 2025
WALTHAM, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced Novasign and Repligen have entered into a strategic partnership to develop and …
Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock
GlobeNewswire
·
July 31, 2025
JUPITER, Fla., July 31, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic” or the “Company”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of high-value, precision engineered functional input proteins for use …
FOXO TECHNOLOGIES INC. ANNOUNCES LICENSE RENEWAL AND PROVIDES OPERATIONAL UPDATE FOR MYRTLE RECOVERY CENTERS, INC.
GlobeNewswire
·
July 31, 2025
WEST PALM BEACH, FLORIDA, July 31, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies, Inc., (NYSE American: FOXO) (“FOXO” or the “Company”) today announced that its behavioral health subsidiary, Myrtle Recovery Centers, Inc., has renewed its operating license for …
HII Reports Second Quarter 2025 Results
GlobeNewswire
·
July 31, 2025
NEWPORT NEWS, Va., July 31, 2025 (GLOBE NEWSWIRE) -- HII (NYSE: HII) today reported results for the second quarter of fiscal 2025. Highlights Second quarter revenues were $3.1 billion Second quarter net earnings were $152 million or $3.86 diluted earnings …
Osisko Development Announces US$195 Million Financing
GlobeNewswire
·
July 31, 2025
Not for distribution to U.S. news wire services or dissemination in the United States. MONTREAL, July 31, 2025 (GLOBE NEWSWIRE) -- Osisko Development Corp. (NYSE: ODV, TSXV: ODV) ("Osisko Development" or the "Company") announces today that it has entered …
Build It. Style It. Show It Off. MGA’s Miniverse™ Launches Make It Mini Spaces™, The Ultimate Way to Create, Customize & Display Your Mini Worlds
GlobeNewswire
·
July 31, 2025
LOS ANGELES, July 31, 2025 (GLOBE NEWSWIRE) -- The original miniature brand where DIY meets collectability, MGA’s Miniverse™, announced today its newest collection, MGA's Miniverse™ Make It Mini Spaces™ Starter Packs and Furniture Packs, expanding the …
Emaar The Economic City وAl Tahaluf توقعان اتفاقية لتنفيذ مشاريع سكنية جديدة في حي المروج بمدينة الملك عبد الله الاقتصادية
GlobeNewswire
·
July 31, 2025
مدينة الملك عبد الله الاقتصادية، المملكة العربية السعودية, July 31, 2025 (GLOBE NEWSWIRE) -- أعلنت شركة Emaar, The Economic City (EEC))، المطوّر الرئيسي لمدينة الملك عبد الله الاقتصادية (KAEC)، عن توقيع اتفاقية مع شركة التحالف العقاري (Al Tahaluf)، وهي …
Apellis Pharmaceuticals Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
July 31, 2025
Received U.S. FDA approval for EMPAVELI® (pegcetacoplan) for treatment of patients 12 years and older with C3G and primary IC-MPGN Announced capped royalty purchase agreement with Sobi under which Apellis receives up to $300 million for 90% of ex-U.S. …
Gilat to Present at the 28th Annual Oppenheimer Technology, Internet & Communications Virtual Conference on Monday, August 11
GlobeNewswire
·
July 31, 2025
PETAH TIKVA, Israel, July 31, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, today announced it will be presenting at the 28th Annual …
Pasithea Therapeutics Completes Enrollment and Initial Dosing of First Cohort from its Phase 1/1b Clinical Trial of PAS-004 in Adult NF1 Patients
GlobeNewswire
·
July 31, 2025
MIAMI, July 31, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor for the treatment of neurofibromatosis …
Arcadia Announces Commitments to Support the CMS-Aligned Network Strategy
GlobeNewswire
·
July 31, 2025
BOSTON, July 31, 2025 (GLOBE NEWSWIRE) -- Arcadia® (arcadia.io), a leading healthcare data platform, today announced deeper industry collaboration to provide customers with a streamlined pathway into the Centers for Medicare …
Allegro MicroSystems Reports First Quarter 2026 Results
GlobeNewswire
·
July 31, 2025
MANCHESTER, N.H., July 31, 2025 (GLOBE NEWSWIRE) -- Allegro MicroSystems, Inc. (“Allegro” or the “Company”) (Nasdaq: ALGM), a global leader in power and sensing semiconductor solutions for motion control and energy efficient systems, today announced …
Electra Begins Testing North American Feedstock for Cobalt Refinery
GlobeNewswire
·
July 31, 2025
TORONTO, July 31, 2025 (GLOBE NEWSWIRE) -- Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”) announces the start of metallurgical testing on cobalt feedstock from two strategic North American sources: the …
BioCryst Announces Charlie Gayer to Succeed Jon Stonehouse as Chief Executive Officer Upon his Retirement in December
GlobeNewswire
·
July 31, 2025
RESEARCH TRIANGLE PARK, N.C., July 31, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that its president and chief executive officer, Jon Stonehouse, has informed the board of directors of his intention to retire on …